Andrew McElligott

Associate

outside the office back to the office
Andrew McElligott
Associate
Overview

Drew focuses his practice on patent and trademark litigation, representing leading companies in the pharmaceutical and medical device sectors, as well as consumer products manufacturers.

Drew has had significant experience at all stages of federal district court litigation and has developed expertise in complex case management, coordination of global discovery efforts, Markman strategy and briefing, and the selection and preparation of expert witnesses. Drew has also gained extensive experience briefing and arguing inter partes reviews, before the United States Patent and Trademark Office.

Before practicing law, Drew worked for four years at the Loyola University Cardiovascular Institute conducting scientific research and gaining expertise in a variety surgical and diagnostic procedures and techniques. Drew now applies the strong analytical and creative problem solving skills that he honed in the laboratory to helping his clients protect their innovations and achieve their long-term goals.

Practice Groups
Education
  • J.D.,
    The John Marshall Law School, 2014
  • B.S., Science Pre-Professional,
    University of Notre Dame, 2007
Bar Admissions
  • Illinois
  • U.S. Court of Appeals, Fed. Cir.
Area of Focus
Experience | Overview
  • Co-authored multiple scientific articles in medical and cardiology publications, and published article on licensing-related issues for the International Trade Commission Trial Lawyers’ Association.
  • Performed extensive legal research as a professor’s assistant at The John Marshall Law School.
  • Served as Lead Articles Editor of The John Marshall Review of Intellectual Property Law.
Experience | Legal
Brinks Gilson & Lione, Chicago, IL
Associate, September 2014-Present
Summer Associate, May 2013-August 2013
Experience | Non-Legal
Loyola University Cardiovascular Institute, Maywood, IL
Research Assistant I and Lead Technician, February 2008-August 2011
Forward Thinking
SCOTUS Agrees To Address Edicts Doctrine For First Time In 130 Years
June 26, 2019
Supreme Court Holds That Copyright Owners Must Wait for Registration Before Filing Suit
March 05, 2019
Only a Patent Owner's Action Triggers § 315(b)'s Time Bar
February 08, 2019
Brinks Webinar | Selected Issues Impacting Biopharma and Medical Device Patent Post-Grant Review Proceedings
November 09, 2017
Brinks Webinar | 2017 Litigation Update
June 14, 2017
Federal Circuit Maintains Pre-AIA Interpretation of the On-Sale Bar for Public Sales
May 16, 2017
Process Limitations Are Not Relevant to the Validity of Pharmaceutical Product Claims
February 05, 2016
Federal Circuit Finds that Laches Remains a Viable Defense in Patent Cases
September 18, 2015
A Higher Bar for Establishing a Licensing-Based Domestic Industry, 37 ITC TRIAL LAW. ASS'N, 337 REP.: The Paul J. Luckern Summer Associate Edition 59 (2013).
2013
Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction, co-author, 52 J. OF MOLECULAR AND CELLULAR CARDIOLOGY 154 (2012).
2012
Novel approach to admittance to volume conversion for ventricular volume measurement, co-author, CONF PROC IEEE ENG MED BIOL SOC. (2011); 2011:2514-7.
2011
Connective Tissue Growth Factor Gene Expression in the Failing Human Heart, co-author, 29 THE J. OF HEART AND LUNG TRANSPLANTATION 61 (Supp. 2010).
2010
Deiodinase Expression in a Rodent Model of Myocardial Infarction, co-author, FASEB J. 23:626.2 (2009).
2009
Presentations
  • "Selected Issues Impacting Biopharma and Medical Device Patent Post-Grant Review Proceedings," Brinks Webinar, November 9, 2017
  • "2017 Litigation Update," Brinks Webinar, June 14, 2017
Press Releases & Events
November 09, 2017
Brinks Webinar | Selected Issues Impacting Biopharma and Medical Device Patent Post-Grant Review Proceedings

On Thursday, November 9, 2017, at 12:00pm CT, David Bernard, Joshua James, and Andrew McElligott, attorneys with Brinks' Post-Grant Patent and Medical Device practice groups, will present the webinar, "Selected Issues Impacting Biopharma and Medical Device Patent Post-Grant Review Proceedings." Jason Schigelone...

November 01, 2017
Attorneys To Address Issues Affecting PTAB Proceedings for Biopharmaceutical and Medical Device Innovations

CHICAGO—Brinks Gilson & Lione intellectual property lawyers David Bernard, Joshua James, and Andrew McElligott will present "Selected Issues Impacting Biopharma and Medical Device Patent Post-Grant Review Proceedings,” in a webinar at noon CST on Thursday, November 9, 2017...

June 14, 2017
Brinks Webinar | 2017 Litigation Update

On Wednesday, June 14, 2017, at 12:00pm CT, the Litigation practice group will present the webinar, "2017 Litigation Update." Attorneys David P. Lindner, James K. Cleland, Alex J. Fernandez, and Andrew McElligott...

September 15, 2014
Brinks Gilson & Lione Adds Nine Associates to Support Growing Demand for Its Intellectual Property Law Expertise
CHICAGO—In response to rising demand for its core intellectual property legal services, Brinks Gilson & Lione recently announced the hiring of nine new associates. Brinks' incoming associates have professional and educational ...
Honors
  • Hon. Howard T. Markey Distinguished Scholar, 2011-2014
  • Lead Articles Editor, The John Marshall Review of Intellectual Property Law
  • Board Member, Trial Advocacy and Dispute Resolution Honors Council
Affiliations
  • The Copyright Society of the USA
  • Phi Alpha Delta Legal Fraternity
  • The Order of John Marshall
Please read our privacy statement. Click here